Characterization of Deaths from Cirrhosis of the Liver in Cuba, 1987-2017

MEDICC Review
|December 9, 2020
PubMed

Insights

Liver cirrhosis mortality in Cuba is increasing, particularly in men and older adults, with nonalcoholic cirrhosis being the leading cause. Forecasts predict continued gradual increases in death rates.

Area of Science:

  • Public Health
  • Epidemiology
  • Gastroenterology

Background:

  • Liver cirrhosis is an irreversible, chronic liver disease representing the final stage of various liver conditions.
  • It is a significant global health burden, ranking as the 11th leading cause of death worldwide.
  • In Cuba, chronic liver diseases, including cirrhosis, have been a leading cause of mortality for decades, with consistently rising rates.

Purpose of the Study:

  • To characterize deaths due to liver cirrhosis in Cuba between 1987 and 2017.
  • To analyze mortality trends, risk factors, and etiological classifications of liver cirrhosis deaths.

Main Methods:

  • An ecological time-series study was conducted using Cuba's national mortality database (1987-2017).
  • Data included deceased individuals with cirrhosis as the underlying cause of death.
  • Mortality rates (crude and age-adjusted) were calculated by age, sex, and etiology, with trend analysis and forecasts performed.

Main Results:

  • The crude mortality rate from liver cirrhosis was 9.0 per 100,000 population over the study period.
  • Mortality rates and relative risk of death were significantly higher in men and individuals aged 75 years and older.
  • Nonalcoholic cirrhosis was the predominant cause, accounting for 71.6% of deaths, and mortality rates showed a progressive increase, with forecasts indicating continued rise.

Conclusions:

  • Deaths from liver cirrhosis represent a substantial public health challenge in Cuba.
  • The observed upward mortality trend, higher risk in men and older adults, and the prevalence of nonalcoholic cirrhosis warrant further investigation and targeted public health strategies.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.6K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
84
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
107
Kubler Ross's Stages of Dying01:21

Kubler Ross's Stages of Dying

Elisabeth Kübler-Ross significantly advanced psychology's understanding of the process of dying with her influential book, On Death and Dying (1969). She focused on studying terminally ill individuals and outlined five stages commonly experienced when coping with death: denial, anger, bargaining, depression, and acceptance.
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...
682
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
366
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
85